What We Do:

The Shenoy Lab at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is interested in understanding and targeting the interactions between aberrant metabolism, epigenetic dysregulation, immune evasion, and hypoxia signaling in cancer. While kidney cancer (clear cell renal cancer) constitutes a large focus, we also undertake select projects in other malignancies. Our research encompasses the ‘bench to bedside to bench’ spectrum.

[The Shenoy Lab started in 2018 at Albert Einstein College of Medicine, New York, and moved to Northwestern University, Chicago, in 2021]